For example, enzyme-linked immunosorbent assay (ELISA) analysis indicated that IDH1 plasma concentrations in the patients with NSCLC were significantly greater than those in patients with benign lung disease and healthy individuals [117]. Here, IDH1 is linked to non-small cell lung carcinoma.